IP Library Granted Patent US 10,131,934
Granted Patent B2
US 10,131,934 · App. 15/805,720 · Granted Nov 20, 2018

Thermal reaction device and method for using the same

Inventors: Marc Unger (San Mateo, CA); Ian D. Manger (New York, NY); Michael Lucero (South San Francisco, CA); Yong Yi (San Francisco, CA); Emily Miyashita-Lin (San Francisco, CA); Anja Wienecke (Hamburg, DE); Geoffrey Facer (San Francisco, CA)
Assignee: Fluidigm Corporation
C12Q1/68B01L3/5025B01L3/5027B01L3/50273B01L3/502707B01L3/502715B01L3/502738C12Q1/686G01N27/453B01L3/0248B01L7/52B01L2200/0642B01L2200/10B01L2200/142B01L2200/147B01L2300/06B01L2300/0636B01L2300/0816B01L2300/0819B01L2300/0861B01L2300/0864B01L2300/0867B01L2300/0874B01L2300/123B01L2300/1805B01L2400/0481B01L2400/0487B01L2400/06B01L2400/0638B01L2400/0655
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,131,934
App. No.
15/805,720
Granted
Nov 20, 2018
Kind
B2
Abstract

A method for carrying out nucleic acid amplification reactions using a microfluidic device is described. Amplification primers and other amplification reagents are deposited at a plurality of reaction sites in the device, a sample solution containing amplifiable polynucleotides is introduced into the reaction sites, and amplification is carried out.

Claims (29)

1. A method for carrying out nucleic acid amplification reactions to detect the quantity, presence, or absence of a plurality of target polynucleotide sequences in a sample, the method comprising:

(a) providing a microfluidic device comprising

(i) an inlet,

(ii) a first flow channel in fluid communication with the inlet, and

(iii) a plurality of second channels in fluid communication with the first flow channel, wherein each second channel comprises an entrance and a dead end,

wherein amplification primers, and optionally other amplification reagents, are non-covalently deposited at reaction sites at the dead ends of each second channel, and amplification primers deposited in different second channels amplify different target polynucleotide sequences,

(b) introducing a sample solution comprising the sample through the inlet such that the sample solution flows through the first flow channel and into the plurality of second channels, wherein the sample comprises a plurality of polynucleotides, and wherein introduction of the sample solution into the second channels causes the deposited amplification primers to be dissolved into the sample solution, and

(c) isolating the reaction sites from the first flow channel and from each other,

(d) conducting polynucleotide amplification reactions in the reaction sites, and

(e) detecting the quantity, presence or absence of polynucleotide amplification products in the reaction sites to determine the quantity, presence, or absence of said target polynucleotide sequences in the sample, wherein in Step (c) an elastomeric membrane is deflected into the plurality of second channels to block flow from said reaction sites to said first channel, thereby isolating the reaction sites from the first flow channel and from each other.

2. The method of claim 1 , wherein the microfluidic device comprises at least 100 reaction sites.

3. The method of claim 2 , wherein the microfluidic device comprises 100 to 1,000 reaction sites.

4. The method of claim 1 , wherein said target polynucleotide sequences comprise viral or bacterial sequences.

5. The method of claim 1 , wherein the target polynucleotide sequences are cDNA sequences.

6. The method of claim 1 , wherein the quantity, presence or absence of polynucleotide amplification products is detected using a DNA intercalation dye.

7. The method of claim 1 wherein primers suitable for multiplex amplifications are deposited in at least one of said reaction sites.

8. The method of claim 1 , wherein the polynucleotide amplification reactions are polymerase chain reactions (PCR).

9. The method of claim 8 , wherein the polynucleotide amplification reactions are real time quantitative polymerase chain reactions.

10. A method for carrying out nucleic acid amplification reactions to detect the presence or absence of a plurality of different target viral or bacterial polynucleotide sequences in a biological sample obtained from a human patient, the method comprising:

(a) providing a microfluidic device comprising

(i) an inlet,

(ii) a first flow channel in fluid communication with the inlet, and

(iii) a plurality of second channels in fluid communication with the first flow channel, wherein each second channel comprises an entrance and a dead end,

wherein amplification primers, and optionally other amplification reagents, are non-covalently deposited at a reaction site at the dead-ends of each second channel, and amplification primers deposited in different second channels amplify different target polynucleotide sequences; and

wherein the different target polynucleotide sequences are viral or bacterial sequences,

(b) introducing a sample solution comprising the sample through the inlet such that the sample solution flows through the first flow channel and into the plurality of second channels, wherein the sample comprises a plurality of polynucleotides, and wherein introduction of the sample solution into the second channels causes the deposited amplification primers to be dissolved into the sample solution,

(c) isolating the reaction sites from the first flow channel and from each other,

(d) conducting polynucleotide amplification reactions in the reaction sites, and

(e) detecting the presence or absence of a polynucleotide amplification products in the reaction sites to determine the presence or absence of a viral or bacterial target polynucleotide sequence in the biological sample obtained from the human patient, wherein in Step (c) an elastomeric membrane is deflected into the plurality of second channels to block flow from said reaction sites to said first channel, thereby isolating the reaction sites from the first flow channel and from each other.

Assignments (2)
CHANGE OF NAME Recorded Sep 15, 2022
From: FLUIDIGM CORPORATION
To: STANDARD BIOTOOLS INC.
Reel/Frame 061448/0305 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2018
From: UNGER, MARC; MANGER, IAN D.; LUCERO, MICHAEL; YI, YONG; MIYASHITA-LIN, EMILY; WIENECKE, ANJA; FACER, GEOFFREY
To: FLUIDIGM CORPORATION
Reel/Frame 046323/0802 →
Continuity (9)
Continuation 14873958 · Oct 2, 2015
Continuation 13548068 · Jul 12, 2012
Continuation 12579347 · Oct 14, 2009
Continuation 11084357 · Mar 18, 2005
Continuation In Part 10876046 · Jun 23, 2004
Continuation In Part 10837885 · May 2, 2004
Continuation In Part 10818642 · Apr 5, 2004
Provisional Application 60460634 · Apr 3, 2003
Related Publication 20180073051A1 · Mar 15, 2018